^
BIOMARKER:

NRAS mutation

i
Other names: NRAS1, HRAS1, N-Ras Protein Part 4, Neuroblastoma RAS Viral (V-Ras) Oncogene Homolog, NRAS, Neuroblastoma RAS Viral Oncogene Homolog, NRAS Proto-Oncogene, GTPase
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
NRAS mutation
Colorectal Cancer
panitumumab
Resistant
:
A1
NRAS mutation
Colorectal Cancer
cetuximab
Resistant
:
A2
NRAS mutation
Melanoma
binimetinib
Sensitive
:
A2
NRAS mutation
Cutaneous Melanoma
binimetinib
Sensitive
:
A2
NRAS mutation
Myelodysplastic Syndrome
ruxolitinib
Sensitive
:
A2
NRAS mutation
Acute Myelogenous Leukemia
gilteritinib
Resistant
:
B
NRAS mutation
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
B
NRAS mutation
Colorectal Cancer
regorafenib
Sensitive
:
B
NRAS mutation
Acute Myelogenous Leukemia
azacitidine
Resistant
:
B
NRAS mutation
Colorectal Cancer
bevacizumab
Sensitive
:
C2
NRAS mutation
Melanoma
AS703026
Sensitive
:
C2
NRAS mutation
Non Small Cell Lung Cancer
LXH254
Sensitive
:
C2
NRAS mutation
Melanoma
FCN-159
Sensitive
:
C2
NRAS mutation
Melanoma
trametinib
Sensitive
:
C2
NRAS mutation
Non Small Cell Lung Cancer
trametinib
Sensitive
:
C2
NRAS mutation
Melanoma
BVD-523
Sensitive
:
C2
NRAS mutation
Melanoma
nivolumab
Sensitive
:
C2
NRAS mutation
Cutaneous Melanoma
AS703026
Sensitive
:
C2
NRAS mutation
Thyroid Gland Carcinoma
selumetinib
Sensitive
:
C2
NRAS mutation
Non Small Cell Lung Cancer
KO-947
Sensitive
:
C2
NRAS mutation
Melanoma
trametinib + palbociclib
Sensitive
:
C2
NRAS mutation
Pancreatic Cancer
avelumab
Sensitive
:
C2
NRAS mutation
Melanoma
KIN-2787
Sensitive
:
C2
NRAS mutation
Multiple Myeloma
selinexor
Sensitive
:
C3
NRAS mutation
Childhood B Acute Lymphoblastic Leukemia
GS-9973
Resistant
:
C3
NRAS mutation
Acute Myelogenous Leukemia
venetoclax
Resistant
:
C3
NRAS mutation
Acute Myelogenous Leukemia
cytarabine
Resistant
:
C3
NRAS mutation
Melanoma
Immunotherapy
Resistant
:
C3
NRAS mutation
Melanoma
trametinib + durvalumab
Sensitive
:
C3
NRAS mutation
Colorectal Cancer
EGFR inhibitor
Resistant
:
C3
NRAS mutation
Acute Myelogenous Leukemia
venetoclax + midostaurin
Resistant
:
C3
NRAS mutation
Acute Myelogenous Leukemia
venetoclax + gilteritinib
Resistant
:
C3